Skip to content

The effect of Lasix in preventing acute kidney injury

The effect of Lasix therapy in preventing acute kidney injury and on the level of Neutrophil Gelatinase Associated Lipocalin in critically hospitalized patients in intensive care unit

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201205092582N8
Enrollment
106
Registered
2012-06-20
Start date
2012-06-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Kidney Injury. Acute renal failure

Interventions

Intervention 1: Intervention group: Intravenous lasix 40-80mg and then maintenance dose of 1-5 mg/h for 7 days. Intervention 2: Control group:standard treatment with placebo for 7 days.
Treatment - Drugs
Intervention group: Intravenous lasix 40-80mg and then maintenance dose of 1-5 mg/h for 7 days
Control group:standard treatment with placebo for 7 days

Sponsors

Tabriz University of medical sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients with Acute Kidney Injury; creatinine rise more than 150-300%, or urine output less than 0.5 cc/kg/h for less than 12 hours Exclusion criteria: previous history of acute kidney injury; dialysis; renal transplantation; urinary tract obstruction; hypovolemia

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Acute Kidney Injury. Timepoint: First, third and seventh day. Method of measurement: Blood Urea Nitrogen?Urea, Urine Output.

Secondary

MeasureTime frame
N-GAL. Timepoint: First, Third and Seventh day. Method of measurement: N-GAL will be measured using USCnlife kit. Blood samples will be taken from the patients and immediately placed in a centrifuge with a round of 3000/min for15 minutes, then poured into the microtube and with maintaining the cold chain, transferred to the - 80 ° C freezer until the time of NGAL assessing.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAta Mahmoodpoor

Tabriz University of Medical Sciences

amahmoodpoor@yahoo.com+98 41 1385 1117

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026